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Abstract 
Introduction and objectives. To determine the proportion of patients with myocardial infarction (MI) not admitted to 
a coronary care unit (CCU), the variables associated with admission into a CCU, and whether admission to a CCU, 
and the availability of coronary angiography in the same hospital, were associated with 28-day case fatality. 
Patients and method. Population-based registry of MI in patients 25 to 74 years of age, admitted during 1996-1998. 
Demographic and clinical characteristics were recorded, as well as management, clinical course and survival after 28 
days. Hospitals were classified according to the availability of a CCU and catheterization laboratory (advanced 
hospital), CCU only (intermediate hospital) or neither (basic hospital). Admission to the CCU was also recorded. 
Results. In all, 9046 cases of MI were recorded; in 11.3% the patient was not admitted to a CCU. Age, smoking 
(OR=1.33; 95% CI, 1.08-1.64), non-Q MI (OR=0.62; 95% CI, 0.49-0.78) or undetermined location of MI (OR=0.34; 
95% CI, 0.23-0.50), Killip 4 score on admission (OR=0.63; 95% CI, 0.40-1.00) and delay in arrival at the hospital >6 
h were associated with CCU admission. Patients admitted to a CCU showed a lower case fatality in the first 24 h 
(4.2% vs 23.5%), which was independent of comorbidity, severity and treatment. The 24-hour survivors admitted to a 
basic hospital had higher case fatality (17.3% vs 7.8%) than other groups, which was related to differences in 
treatment. 
Conclusions. CCU admission is associated with a lower case fatality in the first 24 h. Admission to a basic hospital is 
associated with a higher 28-day case fatality even in patients who survive 24 h. 
Resumen 
Introducción y objetivos. Determinar el porcentaje de pacientes con infarto agudo de miocardio (IAM) que no 
ingresan en una unidad de cuidados intensivos coronaries (UCIC), las variables asociadas al ingreso en una UCIC y si 
el ingreso en una UCIC, su disponibilidad y la de hemodinámica en el hospital se asocian a la letalidad a 28 días. 
Pacientes y método. Registro poblacional (1996-1998) de casos de IAM en pacientes con edades comprendidas entre 
los 25 y los 74 años. Se recogieron variables demográficas, clínicas, el ingreso en UCIC y la letalidad a los 28 días. 
Se clasificaron los hospitales según la disponibilidad de UCIC y hemodinámica (hospital avanzado), solamente UCIC 
(hospital intermedio) o ninguno (hospital básico). 
Resultados. Se registraron 9.046 casos; el 11,3% no ingresó en una UCIC. La edad, el consumo de tabaco (odds ratio 
[OR] = 1,33; intervalo de confianza [IC] del 95%, 1,08-1,64), el infarto sin onda Q (OR = 0,62; IC del 95%, 0,49-
0,78) o ilocalizable (OR = 0,34; IC del 95%, 0,23-0,50), el grado Killip 4 al ingreso (OR = 0,63; IC del 95%, 0,40-
1,00) y el retraso > 6 h en llegar al hospital se asociaron al ingreso en UCIC. Los pacientes ingresados en UCIC 
presentaban menor letalidad que los ingresados en hospitales básicos en las primeras 24 h (el 4,2 frente al 23,5%), 
independientemente de la gravedad del IAM y de las variables relacionadas con el tratamiento. Los su-pervivientes a 
24 h que ingresaban en un hospital bÁsico presentaban mayor letalidad a los 28 días (el 17,3 frente al 7,8%), 
relacionada con las variables de tratamiento. 
Conclusiones. El ingreso en una UCIC se asocia a una menor letalidad de los pacientes con IAM en las primeras 24 h. 
El ingreso en un hospital bÁsico se asocia a una mayor letalidad a los 28 días. 
  
Key words 
Epidemiology; Myocardial infarction; Mortality; Fatality 
 
Palabras clave 
Epidemiología; Infarto de miocardio; Mortalidad; Letalidad 
 
ABBREVIATIONS 
IBERICA:, Investigación, Búsqueda Específica y Registro de Isquemia Coronaria Aguda [Research, Specific Search 
and Registry of Acute Coronary Ischemia]; AMI:, acute myocardial infarction; CCU:, coronary care unit; 
PRIAMHO:, Proyecto de Registro de Infarto Agudo de Miocardio Hospitalario [Project for a Hospital Registry of 
Acute Myocardial Infarction]; MONICA:, Monitoring the Trends and Determinants of Cardiovascular Disease 
Introduction 
More than 74 000 patients are hospitalized every year in Spain for acute myocardial infarction (AMI) 
or unstable angina.1  The recommendations contained in the basic guidelines indicate that patients with 
AMI should be treated in a coronary care unit (CCU) or other hospital area with the capability for 
continuous electrocardiographic monitoring and defibrillation for at least the first 48 hours of the acute 
phase.2-4 
Furthermore, the relationship between coronary angiography usage in patients with AMI and mortality 
continues to be a subject for debate.5-9  On-site availability of the technique leads to greater usage, 5,8,10  
although its implementation is not always associated with lower mortality5,7,8  but is probably associated 
with better quality of life.11 
The Spanish Ley General de Sanidad [General Health Act] of 198612  and the Spanish Ley de 
Cohesión y Calidad del Sistema Nacional de Salud [National Health System Cohesion and Quality Act] 
of 200313  establish the principle of equal and universal coverage in the public healthcare system, ensuring 
access to healthcare benefits under conditions of effective equality. 
Several studies have analyzed variability in the management of patients with AMI in Spanish CCUs 
and the relationship between this variability and prognosis,7,14,15  but few have included patients who were 
not admitted to a CCU.5,6,16 
The purpose of this study was to determine the percentage of AMI patients who were not admitted to a 
CCU and the variables associated with CCU admission, as well as to evaluate whether the availability of 
a CCU or catheterization laboratory at the hospital where the patient spent most of the first 72 hours from 
the onset of symptoms was associated with 28-day case-fatality. 
Patients and methods 
Design 
The IBERICA study (Investigación, Búsqueda Específica y Registro de Isquemia Coronaria Aguda; 
Research, Specific Search and Registry of Acute Coronary Ischemia) is a population-based registry of 
patients with AMI among 25- to 74-year-old residents in various areas of the Balearic Islands, Basque 
Country, Castilla-La Mancha, Catalonia, Murcia, Navarra, and Valencia. The study period was 1 July 
1996 to 31 December 1998 in most of the areas. According to official projections, the referral population 
in the areas for the study period was 3 638 940 men and 3 725 742 women. 
Patients 
All patients with AMI admitted to a CCU in the participating areas were prospectively recorded. In 
addition, all medical histories were reviewed for all patients with codes 410-414 of the International 
Classification of Diseases, Ninth Revision, listed as a diagnosis at discharge from hospitals in the 
participating areas. The emergency department records and the emergency health transport records were 
also reviewed to identify cases transferred to referral hospitals outside the study area. In patients who 
presented several episodes of AMI, each event was recorded as a separate case. 
The standardized criteria of the MONICA study17  were used for the AMI diagnosis. The analysis 
included patients arriving at a hospital alive and classified as definite AMI, whether alive or dead, as well 
as possible cases in which the patient died after arrival to the hospital. In summary, the cases were 
classified as: a) definite AMI, when a Q-wave appeared in the electrocardiogram or when 
electrocardiographic abnormalities were observed suggesting ischemia with typical symptoms and 
myocardial enzyme levels (creatine kinase [CK]) greater than twice the upper limit of normality, and 
when there was a fatal event with signs of coronary thrombosis or recent myocardial necrosis on autopsy, 
and b) possible infarction, when patients did not have the criteria of definite infarction and died having 
presented typical symptoms, or when they presented signs of coronary arteriosclerosis or ischemic heart 
disease on autopsy. 
Follow-up and Events of Interest 
The main event of interest during follow-up was 28-day case-fatality. All deaths occurring during the 
first 28 days post-AMI and considered to be related to the index event were recorded. Patients’ vital status 
at 28 days was ascertained by a review of the medical history, contact with the attending physician or the 
death registry. A distinction was made between 24-h mortality and mortality occurring between 24 h and 
28 days from the onset of symptoms. 
Variables Measured 
The factor of interest analyzed was the type of hospital where the patient stayed for most of the first 
72 h from the onset of symptoms. The hospitals were classified as one of the following: a) basic hospital 
if there was no CCU or catheterization laboratory; b) intermediate hospital if there was a CCU but no 
catheterization laboratory, and c) advanced hospital if both a CCU and a catheterization laboratory were 
available. In addition, the patients from the intermediate and advanced hospitals were classified according 
to whether or not they had been admitted to a CCU. In accordance with the definition of the PRIAMHO 
(Proyecto de Registro de Infarto Agudo de Miocardio Hospitalario, Project of a Hospital Registry for 
Acute Myocardial Infarction) study,14,15  this analysis looked at all patients admitted to a CCU or general 
intensive care unit (ICU) that handled coronary patients. 
Data were also compiled with regard to demographic information, clinical characteristics, comorbidity 
(hypertension, diabetes, and heart failure), smoking, complications (maximum Killip class, severe 
ventricular arrhythmia), as well as the delay between the onset of symptoms and arrival at the hospital 
and the diagnostic and therapeutic procedures carried out during the hospital stay. 
Quality Control 
In order to ensure the homogeneity of the methods and the data compiled, the investigators were 
trained and accredited for the study by the coordinating center. Intraobserver and interobserver agreement 
when categorizing a set of index cases was analyzed, obtaining Kappa indices of agreement >0.90 for all 
investigators. In addition, the coordinating center blindly assigned a diagnostic category to each case by 
means of an automatic algorithm. If there was any disagreement between the coordinating center and the 
principal investigator, the case was reviewed and a diagnostic category was agreed. 
Statistical Analysis 
Continuous variables are presented as the mean and standard deviation, and were compared between 
groups by a Student’s t test or analysis of variance. Categorical variables are shown as percentages and 
were compared between groups by a chi-square test. For the trend analysis between hospital types, the 
chisquare test for trends was used in the case of categorical variables, and the Spearman correlation for 
ordinal variables. 
Logistic regression was used to identify the variables associated with CCU admission and to estimate 
the odds ratio (OR) and 95% confidence interval (CI) for mortality of admitted patients at 28 days, within 
the first 24 hours and from 24 hours to 28 days, according to hospital type and CCU admission, adjusted 
for the main confounding factors. Variables that differed by a significance level of P <.15 in the bivariate 
analysis between hospital types and that were also associated with the dependent variable (28-day case-
fatality) were considered potential confounding factors. Clinically relevant variables were also 
considered. When analyzing the association between hospital type and case-fatality, four different models 
were defined. Models 1 and 2 were adjusted for age and sex, and for comorbidity, respectively. In order 
to assess whether the differences observed were related to AMI severity and management, the model 
included Killip class and the presence of malignant ventricular arrhythmia in addition to comorbidity 
(Model 3) and treatment with thrombolysis and aspirin therapy (Model 4). SPSS 10.0 was used for the 
calculations. 
Results 
During the study period, 9304 patients with AMI were recorded at the hospitals in the participating 
areas. Among these, the treatment hospital type in the first 72 hours or CCU admission was unknown in 
258 patients (2.8%). Among the 9046 patients with AMI included in the analysis, 202 (2.2%) were 
admitted to a basic hospital, 359 (4.0%) to an intermediate hospital but not admitted the CCU, 459 (5.1%) 
to an advanced hospital but not the CCU, 3396 (37.5%) to the CCU in an intermediate hospital, and 4630 
(51.2%) to the CCU in an advanced hospital. This distribution showed considerable variability, depending 
on the area participating in the study (Figure). A total of 1020 patients (11.3%; 95% CI, 10.6%-11.9%) 
were not admitted to a CCU. When analyzing those who arrived within the first 48 hours of onset, this 
percentage was 8.0%. 
 
 
 
Fig. 1. Distribution of the 9046 patients of the IBERICA study by area, according to treatment 
hospital type and admission to a coronary care unit (CCU). Basic hospital: no CCU or 
catheterization laboratory; Intermediate hospital: CCU, but no catheterization laboratory; 
Advanced hospital: CCU and catheterization laboratory 
Table 1 indicates the patient characteristics according to treatment hospital type and admission to a 
CCU. The patients admitted to basic hospitals were significantly older, more often women, non-smokers 
and diabetics, and had a more extensive history of angina and congestive heart failure than the others. 
These patients received less thrombolysis, antiplatelet therapy, beta-blockers and angiotensin-converting 
enzyme (ACE) inhibitors than patients from the other hospitals, and were less likely to undergo coronary 
angiography, stress tests and echocardiography (Table 2). Patients who were admitted to an intermediate 
or advanced hospital but not admitted to a CCU presented intermediate characteristics between the 
patients in basic hospitals and those in intermediate or advanced hospitals who were admitted to a CCU, 
and a linear trend was observed between these defined groups (Tables 1 and 2). 
  
Table 1. Patient History and Characteristics of AMI Episode in Patients Participating in the IBERICA Study by the Type of Hospital and Admission in 
CCU (n=9046)* 
 Type of Hospital and Admission in CCU   
 
Basic 
(n=202) 
Intermediate, 
Non-CCU 
(n=359) 
Advanced, 
Non-CCU 
(n=459) 
Intermediate, 
CCU (n=3396) 
Advanced, 
CCU (n=4630) 
P Trend P† 
 
Cardiovascular risk factors 
Age, mean±SD  66.2±7.8 63.9±9.5 63.1±9.2 61.5±10.0 60.3±10.4 <.001 <.001‡ 
Women, %  34.7 29.0 24.4 20.5 18.0 <.001 <.001 
Hypertension, %  50.8 55.4 53.9 45.4 44.4 <.001 <.001 
Diabetes, %  39.9 37.8 33.0 29.5 27.3 <.001 <.001 
Smoking, %  24.2 28.7 36.1 44.0 47.5 <.001 <.001 
Prior history 
Previous angina, %  50.8 44.8 44.9 42.7 40.9 .021 .001 
Previous AMI, %  24.6 22.8 27.1 16.4 16.9 <.001 <.001 
Heart failure, %  12.6 13.4 14.7 5.8 6.0 <.001 <.001 
Characteristics of the event 
No monitoring, 30 min$ 120 170 155 120 120   
(median [P5-P95])  (15-2664) (15-2880) (0-2880) (20-1440) (10-1278) <.001 <.001 
Anterior AMI  34.9 38.8 30.5 35.1 35.2 . 221 . 938 
Non-Q-wave AMI  16.9 14.4 23.1 15.1 14.3 <.001 <.001 
Killip at admission ≥3  13.4 16.7 17.5 8.6 8.3 <.001 <.001 
        
 
*SD indicates standard deviation; AMI, acute myocardial infarction; CCU, coronary care unit.  
† P trend: chi-square for trends.  
‡ P trend by Spearman correlation coefficient. 
$ Median (5th percentile and 95th percentile).  
Table 2. Diagnostic and Therapeutic Procedures, Complications of the AMI Episode in IBERICA Study Subjects According to Treatment Hospital Type 
and Admission to CCU (n=9046)* 
 Type of Hospital and Admission in CCU   
 
Basic 
(n=202) 
Intermediate, 
Non-CCU 
(n=359) 
Advanced, 
Non-CCU 
(n=459) 
Intermediate, 
CCU (n=3396) 
Advanced, 
CCU 
(n=4630) 
P P Trend† 
 
Drugs, % 
Thrombolysis  6.4 19.5 11.1 50.4 43.9 <.001 <.001 
ASA  77.3 79.5 76.8 96.6 96.4 <.001 <.001 
Beta-blockers  24.9 30.3 39.5 52.7 56.2 <.001 <.001 
ACE inhibitors  33.0 40.4 35.8 51.5 47.6 <.001 <.001 
Procedures, % 
Coronary angiography  4.8 18.3 23.7 27.9 39.5 <.001 <.001 
Echocardiography  26.4 54.8 66.1 73.0 82.8 <.001 <.001 
Stress test  19.9 30.8 37.1 51.9 50.3 <.001 <.001 
Surgery  0.5 0.9 0.7 2.3 4.3 <.001 <.001 
Coronary angioplasty 1.6 5.5 9.0 11.6 21.2 <.001 <.001 
Complications in acute phase, % 
Severe arrhythmias  18.1 18.2 17.8 12.0 14.5 <.001 .187 
Maximum Killip ≥3  25.7 27.0 24.1 18.0 17.5 <.001 <.001 
Case-fatality, % 
0-28 days  38.1 33.7 29.6 11.5 11.6 <.001 <.001 
0-1 h  3.5 4.2 5.4 0.3 0.5 <.001 <.001 
0-24 h  22.3 25.9 22.2 4.4 4.1 <.001 <.001 
24 h-28 days  20.4 10.5 9.5 7.5 7.8 <.001 <.001 
        
 
* ASA indicates antiplatelet therapy; AMI, acute myocardial infarction; ACE inhibitors, angiotensin-converting enzyme inhibitors ; 
CCU, coronary care unit. † P trend: chi-square for trends 
  
The 28-day case-fatality was 38.1% in the basic hospitals, around 30% in the intermediate and 
advanced hospitals in the patients not admitted to the CCU, and 11% in patients at intermediate and 
advanced hospitals who were admitted to the CCU (Table 2). The patients in the basic hospitals presented 
higher case-fatality within the first 24 hours and during the period of 24 hours to 28 days. Patients from 
the intermediate or advanced hospitals who were not admitted to a CCU had higher case-fatality with 
respect to those who were admitted to a CCU, although this difference was observed primarily in the first 
24 hours (Table 2). 
In the subgroup of patients who arrived within the first 48 hours after onset of AMI, the variables 
independently associated with admission to a CCU were analyzed (Table 3). Older patients and smokers 
had a greater probability of being admitted to a CCU, whereas non-Q-wave infarction or infarction of 
indeterminate location on the electrocardiogram, Killip class 4 at admission and delay in arrival to the 
hospital above 6 hours were associated with a lower probability of admission to a CCU. 
Table 3. Associated Variables Regardless of Admission to CCU* 
 OR (95% CI) P 
   
Age   
25-54 years  1  
55-64 years  1.47 (1.14-1.92) .004 
65-74 years  1.29 (1.03-1.60) .024 
Sex, female  0.85 (0.69-1.06) .140 
Smoking  1.33 (1.08-1.64) .008 
Hypertension  0.84 (0.70-1.01) .057 
Location   
Inferior AMI  1  
Non-Q-wave  0.62 (0.49-0.78) <.001 
Anterior  0.89 (0.73-1.10) .282 
Unclassifiable  0.34 (0.23-0.50) <.001 
Killip at admission   
1 1  
2  0.90 (0.71-1.15) .400 
3  0.76 (0.54-1.07) .113 
4  0.63 (0.40-1.00) .049 
Symptoms-monitoring   
0-2 h 1  
2-4 h  1.12 (0.87-1.42) .378 
4-6 h  1.01 (0.71-1.42) .967 
6-12 h  0.66 (0.50-0.87) .003 
12-24 h  0.71 (0.50-0.99) .045 
24-36 h  0.61 (0.32-1.16) .134 
36-48 h  0.27 (0.17-0.41) <.001 
   
 
* AMI indicates acute myocardial infarction; CI, confidence interval; OR, odds ratio; 
CCU, coronary care unit. Patients admitted to the hospital within the first 48 hours and 
with valid information on the delay in arrival at the hospital were selected (n=7708) 
Table 4 indicates the patient characteristics, according to vital status at 28 days. The variables that 
differed between patients according to the hospital type were also associated with higher 28-day case-
fatality. 
  
Table 4. Variables Associated With 28-Day Mortality After AMI in Patients in the IBERICA Study (n=9046)* 
 Survivors (n=7782) Deaths (n=1264) P 
 
Cardiovascular risk factors 
Age, mean±SD  60.5±10.3 65.5±8.1 <.001 
Sex, women (%)  18.8 27.9 <.001 
Hypertension, %  44.5 54.8 <.001 
Diabetes, %  26.8 43.3 <.001 
Current smokers, %  47.0 27.6 <.001 
Prior history, % 
Previous angina  40.9 50.3 <.001 
Previous AMI  15.5 31.3 <.001 
Heart failure  4.8 20.0 <.001 
Characteristics of the event, % 
Anterior location on ECG  34.1 41.9 <.001 
Non-Q-wave AMI  15.5 11.3 <.001 
Killip at admission ≥3  5.1 39.0 <.001 
Drugs, % 
Thrombolysis  45.7 25.2 <.001 
Antiplatelet therapy  98.6 66.4 <.001 
Beta-blockers  58.1 14.1 <.001 
ACE inhibitors  51.3 25.1 <.001 
Procedures, % 
Coronary angiography  35.8 13.9 <.001 
Surgery  3.2 3.2 .928 
Coronary angioplasty  17.4 6.1 <.001 
Complications in acute phase, % 
Tachycardia/ventricular fibrillation 9.2 46.9 <.001 
Maximum Killip ≥3  10.7 73.0 <.001 
    
 
* SD indicates standard deviation; ECG, electrocardiogram; AMI, acute myocardial infarction; ACE inhibitors, angiotensin-
converting enzyme inhibitors 
When analyzing the association between the case fatality and the hospital type and CCU admission, 
admission to a CCU (whether in an intermediate or advanced hospital) was found to be associated with 
lower 28-day case-fatality (Table 5). This lower mortality remained the same, even after adjusting for 
AMI severity (Model 3), and for variables related to the AMI treatment (Model 4). Admission to an 
advanced hospital without admission to a CCU was also associated with lower 28-day case-fatality. 
  
Table 5. Adjusted Odds Ratio (OR) and 95% CI for Overall 28-Day Case-Fatality, 24-h Case-Fatality and 1- to 28-Day Case-
Fatality Among 24-h Survivors, According to Treatment Hospital Type and Admission or Not to CCU* 
 OR (95% CI) 
 Model 1a Model 2b Model 3c Model 4dI 
     
28-day mortality     
Basic  1 1 1 1 
Intermediate, non-CCU  0.92 (0.64-1.32) 0.63 (0.37-1.05) 0.43 (0.22-0.85) 0.54 (0.26-1.14) 
Advanced, non-CCU  0.79 (0.55-1.12) 0.54 (0.32-0.92) 0.34 (0.17-0.67) 0.34 (0.16-0.71) 
Intermediate, CCU  0.25 (0.19-0.35) 0.36 (0.23-0.55) 0.25 (0.14-0.43) 0.41 (0.23-0.73) 
Advanced, CCU  
0.27 (0.20-0.37) 
n=9046 
0.41 (0.26-0.64) 
n=8310 
0.27 (0.15-0.48) 
n=8196 
0.49 (0.27-0.90) 
n=7873 
24-h mortality     
Basic  1 1 1 1 
Intermediate, non-CCU  1.31 (0.87-1.97) 0.87 (0.45-1.71) 0.65 (0.28-1.47) 0.59 (0.24-1.47) 
Advanced, non-CCU  1.10 (0.73-1.64) 0.82 (0.41-1.65) 0.62 (0.27-1.46) 0.49 (0.20-1.24) 
Intermediate, CCU  0.18 (0.13-0.27) 0.27 (0.15-0.48) 0.23 (0.11-0.46) 0.28 (0.13-0.58) 
Advanced, CCU  
0.18 (0.12-0.26) 
n=9046 
0.29 (0.16-0.53) 
n=8310 
0.22 (0.10-0.45) 
n=8196 
0.30 (0.14-0.65) 
n=7873 
24-h to 28-day mortality, in 24-h 
survivors 
    
Basic  1 1 1 1 
Intermediate, non-CCU  0.54 (0.31-0.95) 0.57 (0.29-1.14) 0.49 (0.22-1.13) 0.58 (0.24-1.38) 
Advanced, non-CCU  0.48 (0.28-0.82) 0.44 (0.22-0.88) 0.31 (0.13-0.70) 0.29 (0.12-0.71) 
Intermediate, CCU  0.41 (0.27-0.62) 0.51 (0.30-0.86) 0.35 (0.18-0.67) 0.53 (0.27-1.04) 
Advanced, CCU  
0.46 (0.31-0.70) 
n=8465 
0.60 (0.35-1.05) 
n=7967 
0.39 (0.20-0.77) 
n=7885 
0.63 (0.31-1.28) 
n=7573 
     
 
* CI indicates confidence interval; CCU, coronary care unit. a Model 1: adjusting for age and sex. b Model 2: adjusting for age, sex, 
smoking, hypertension, diabetes, AMI location and prior history of AMI, angina, or heart failure. c Model 3: adjusting for the same 
variables as Model 2, as well as maximum Killip during admission and malignant ventricular arrhythmia as indicators of severity. d 
Model 4: adjusting for the same variables as Model 3, as well as thrombolysis, antiplatelet therapy, and coronary angiography as 
indicators of patient treatment 
Furthermore, admission to a CCU was associated with lower 24-hour case-fatality. This lower case-
fatality remained the same, even after adjusting for AMI severity or for the treatment-related variables. 
These results remained unchanged when the patients who survived the first hour were selected, in both 
intermediate (OR=0.31; 95% CI, 0.17-0.57) and advanced hospitals (OR=0.30; 95% CI, 0.16-0.57). 
When the analysis was limited to 24-hour survivors, it was observed that admission to an intermediate 
(in the CCU) or advanced hospital (regardless of admission to a CCU or not) was associated with lower 
28-day case-fatality. This association persisted even after adjusting for the severity of the AMI. The type 
of hospital where the patient was treated no longer had a protective effect against mortality, except when 
the patient was admitted to an advanced hospital but not a CCU, which continued to be associated with 
lower case-fatality after adjusting for the variables related to AMI treatment (antiplatelet therapy, 
thrombolysis, and coronary angiography). After adjusting for antiplatelet therapy and thrombolysis or for 
angiography coronary in two different models, admission to a CCU or to an advanced hospital but not to a 
CCU was still associated with lower case-fatality (data not shown). 
An analysis to determine whether admission to a CCU or general ICU was associated with different 
mortality showed no differences in 28-day case-fatality (admission to a general ICU versus a CCU, 
OR=0.96; 95% CI, 0.73-1.25). 
  
Discussion 
In this population-based hospital registry of patients with AMI, we observed that about 11% of the 
patients between 25 and 74 years of age who were admitted to a hospital for AMI were not admitted to a 
CCU. Older patients and smokers had a greater probability of being admitted to a CCU, whereas a delay 
in hospital arrival, Killip class 4 at admission and non-Q-wave or infarction of indeterminate location 
were associated with a lower probability of admission. Non-admission to a CCU was associated with 
higher 28-day case-fatality, mainly at the expense of greater mortality in the first 24 hours. 
This registry also showed that around 2% of the patients with AMI were admitted to a basic hospital. 
This admission was associated with higher 28-day case-fatality in 24-hour survivors, an outcome partially 
explained by differences in treatment. 
Admission to a CCU and Associated Variables 
Despite the recommendations of the treatment guidelines,2-4  it is interesting to note that 11.3% of the 
patients were not admitted to a CCU. 
The evidence suggests that more seriously ill patients could benefit most from treatment in a CCU.18  
Paradoxically, in our study the group of patients who were not admitted to a CCU presented a poorer 
baseline profile, greater frequency of high Killip class at admission and during hospitalization, and a 
higher incidence of malignant ventricular arrhythmia than those admitted to a CCU. In addition, Killip 
class 4 at admission was associated with a lower probability of admission to a CCU in the multivariate 
analysis. These data are consistent with the findings of a study conducted in the United States, which 
showed that AMI patients transferred from a community hospital to a tertiary hospital had a lower score 
on the severity scales and significantly lower 30-day case-fatality than patients who were not 
transferred.19 
In this context, the use of risk stratification algorithms for patients with AMI based on easy-to-
measure clinical characteristics at the time of admission are recommended to establish the best 
therapeutic approach.18  The Integrated Ischemic Heart Disease Plan in Spain underscores the fact that a 
broad difference in the use of effective diagnostic and therapeutic procedures is not acceptable, because 
of the potential impact on patient mortality and morbidity.20 
Another interesting point is that most patients seen in basic hospitals were found in Girona. This is 
probably the result of the health structure used in Catalonia, in which an emphasis has been placed on 
hospital proximity to the non-urban population over hospital specialization. Nevertheless, the total sum of 
patients seen in the basic hospitals and those not admitted to a CCU does show considerable variability 
between areas, suggesting that CCU accessibility is similar in the areas studied. 
Type of Hospital, Admission to a CCU and Case-Fatality 
The higher case-fatality observed in patients not admitted to a CCU could be related to 3 factors: 
differences in the characteristics of patients admitted to the various hospital types defined, differences in 
AMI treatment in these hospitals, or differences in the accessibility of secondary and tertiary resources.  
The greater comorbidity and severity of patients not admitted to a CCU could explain the greater 
mortality.21,22  Nevertheless, in our study these variables did not explain the entire difference in 28-day 
and 24-hour case-fatality observed. Furthermore, differences in treatment did not explain the higher 24-
hour case-fatality of patients not admitted to a CCU, although it did explain the lower 24-h to 28-day 
case-fatality in the case of patients admitted to a CCU. These observations reaffirm the importance of 
CCUs in treatment during the early hours of AMI. Although the results were the same when selecting the 
survivors at one hour after the onset of symptoms, we cannot rule out the possibility that these patients 
died due to AMI severity within the first few hours and therefore could not be admitted to a CCU. 
Another important observation is that patients treated in a basic hospital presented a higher 24-h to 28-
day case-fatality rate, regardless of the comorbidity and severity of the AMI. The lower use of 
thrombolysis, antiplatelet therapy and coronary angiography partially explained this higher case-fatality. 
In our study, the overall use of thrombolysis (43%) was less than that observed in series of patients 
admitted to the CCU,23  particularly in basic hospitals (6.4%). The same conclusions are obtained when 
analyzing the use of antiplatelet therapy, beta-blockers, and ACE inhibitors. This variability in treatment 
between hospitals has already been reported in patients admitted to the CCU,14,15  but is even greater when 
patients not admitted to the CCU are included.16  These results support the need to disseminate and use 
clinical practice guidelines for the treatment of AMI 2 based on the best scientific evidence available, in 
order to decrease mortality. 
Differences in the accessibility of tertiary resources could also explain this higher case-fatality. In our 
study, more coronary angiographies and angioplasties were performed in the advanced hospitals than the 
intermediate and basic hospitals, lending support to the hypothesis suggested by previous studies5,6,8  that 
the number of diagnostic and therapeutic procedures the patient receives is determined mainly by the 
resources available at the admitting hospital. Nevertheless, we did not observe significant differences in 
28-day case-fatality when comparing intermediate and advanced hospitals. In addition, when adjusting 
the analyses for the use of coronary angiography without including the medical therapies (antiplatelet 
therapy and thrombolysis), the association between admission to a CCU or an advanced hospital 
continued to be associated with a lower case-fatality. These data are consistent with the results of other 
observational studies indicating that the variability in the use of tertiary procedures does not appear to 
determine differences in the short- to medium-term case-fatality between intermediate and advanced 
hospitals if the patients with an indication for urgent coronary angiography at the intermediate centers are 
referred to advanced centers.5,8-10 
The lower case-fatality observed in these hospitals is probably related to multiple factors, such as 
improved treatment and greater accessibility of secondary and tertiary resources. 
A recent publication based on the minimum basic data set showed that the raw and adjusted in-
hospital case-fatality for ischemic heart disease and heart failure in the best general and teaching hospitals 
in Spain was above the case-fatality observed in the best county hospitals.24  The difference with our 
results, which showed a higher raw case-fatality in basic hospitals, probably can be attributed to the fact 
that the former did not include patients who died in the emergency room prior to admission to the hospital 
and included patients with heart failure as well as forms of ischemic heart disease other than AMI. 
Characteristics and Limitations of the Study 
This analysis was based on a population-based hospital registry in various regions of Spain that 
allowed patients not admitted to a CCU or remaining in basic hospitals to be characterized and 
comparatively analyzed with regard to clinical progress. These patients rarely participate in 
epidemiological or clinical studies on AMI treatment. 
The data of patients not admitted to a CCU were compiled retrospectively from the clinical history, 
and it was impossible to analyze the clinical evidence used to limit access to the CCU (terminal status or 
extremely limited quality of life, for instance). 
Conclusions 
One out of every ten patients between 25 and 74 years of age who presented an AMI and arrived at a 
hospital alive were not admitted to a CCU. Many of these patients, particularly the most severe cases 
(Killip 4 at admission), could benefit from CCU admission. CCU admission was associated with lower 
28-day case-fatality, particularly within the first 24 hours, regardless of whether the hospital where the 
patient was admitted had a catheterization laboratory. 
Admission to a CCU, or to a hospital with a catheterization laboratory but not to a CCU, was 
associated with lower 24-h to 28-day case-fatality, with respect to admission in a basic hospital. 
Differences in thrombolysis, antiplatelet therapy, and coronary angiography partially explain this 
observation. 
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